Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Charlotte F Kweldam
Affiliation
Anser Prostate Operation Clinic, Maasstad Hospital
ORCID
Career Start Year
2011
Papers
34
H Index
20
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37032279
Urinary Incontinence and Sexual Function After the Introduction of NeuroSAFE in Radical Prostatectomy for Prostate Cancer.
Eur Urol Focus
2023
37407736
Reliability of whole mount radical prostatectomy histopathology as the ground truth for artificial intelligence assisted prostate imaging.
Virchows Arch
2023
37140551
Biopsy prostate cancer perineural invasion and tumour load are associated with positive posterolateral margins at radical prostatectomy: implications for planning of nerve-sparing surgery.
Histopathology
2023
36190529
Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern.
World J Urol
2022
35384019
Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies.
Histopathology
2022
35536200
NeuroSAFE in radical prostatectomy increases the rate of nerve-sparing surgery without affecting oncological outcome.
BJU Int
2022
31439369
Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
Eur Urol
2020
31876580
Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.
Am J Surg Pathol
2020
31904279
Comparison of Tumor Volume Parameters on Prostate Cancer Biopsies.
Arch Pathol Lab Med
2020
32913202
Automated detection of cribriform growth patterns in prostate histology images.
Sci Rep
2020
32542746
Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens.
Histopathology
2020
32459716
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.
Am J Surg Pathol
2020
30528698
Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore.
Urol Oncol
2019
30565302
Grading of prostate cancer: a work in progress.
Histopathology
2019
29094386
Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3Â +Â 4Â =Â 7 and highest Gleason score 3Â +Â 4Â =Â 7 or >Â 3Â +Â 4Â =Â 7.
Histopathology
2018
29594028
On cribriform prostate cancer.
Transl Androl Urol
2018
29295717
Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
BMC Cancer
2018
28530220
Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.
Mod Pathol
2017
28173626
Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam.
Int J Urol
2017
28162815
Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Eur Urol
2017
28511883
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.
Eur Urol
2017
26233533
Reply to Masaki Shiota and Akira Yokomizo's Letter to the Editor re: Robert J. van Soest, Ellen S. de Morrée, Charlotte F. Kweldam, et al. Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer. Eur Urol 2015;67:981-5.
Eur Urol
2016
27353346
Three-dimensional microscopic analysis of clinical prostate specimens.
Histopathology
2016
27522247
Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.
Eur J Cancer
2016
26939875
Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy.
Mod Pathol
2016
27028587
Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.
Histopathology
2016
24592810
Neonatal head ultrasonography today: a powerful imaging tool!
J Neuroimaging
2015
25686826
Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer.
Oncotarget
2015
25484141
Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer.
Eur Urol
2015
25060593
Disease-specific death and metastasis do not occur in patients with Gleason score ⿤6 at radical prostatectomy.
BJU Int
2015
25189638
Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.
Mod Pathol
2015
24771489
Undecussated superior cerebellar peduncles and absence of the dorsal transverse pontine fibers: a new axonal guidance disorder?
Cerebellum
2014
25243131
Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review.
Biomed Res Int
2014
20888312
The incidence of craniosynostosis in the Netherlands, 1997-2007.
J Plast Reconstr Aesthet Surg
2011
1 - 34 of 34
Column Actions
Search
Recommended Authors
Mehdi Masoomian
University Health Network
Career Start Year
2019
Number of shared co-authors
9
Susan Prendeville
University of Toronto
Career Start Year
2013
Number of shared co-authors
15
Neil Mendhiratta
National Cancer Institute, National Institutes of Health
Career Start Year
2013
Number of shared co-authors
2
Francesco Pellegrino
Urological Research Institute, IRCCS San Raffaele Hospital
Career Start Year
2012
Number of shared co-authors
2
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year
2012
Number of shared co-authors
6
Steven Hazell
Royal Marsden NHS Foundation Trust
Career Start Year
2011
Number of shared co-authors
5
Jeffrey J Tosoian
Vanderbilt University Medical Center
Career Start Year
2008
Number of shared co-authors
5
Fadi Brimo
McGill University Health Centre, McGill University
Career Start Year
2007
Number of shared co-authors
20
Alastair D Lamb
University of Oxford
Career Start Year
2007
Number of shared co-authors
21
Michelle R Downes
University of Toronto
Career Start Year
2006
Number of shared co-authors
9
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year
2004
Number of shared co-authors
7
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year
2004
Number of shared co-authors
11
Ashley E Ross
Northwestern University
Career Start Year
2003
Number of shared co-authors
9
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Career Start Year
2002
Number of shared co-authors
9
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year
2001
Number of shared co-authors
19
Robert Jeffrey Karnes
Mayo Clinic
Career Start Year
2000
Number of shared co-authors
7
Vincent J Gnanapragasam
University of Cambridge
Career Start Year
1999
Number of shared co-authors
8
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year
1998
Number of shared co-authors
8
Todd M Morgan
University of Michigan ann arbor
Career Start Year
1997
Number of shared co-authors
7
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1997
Number of shared co-authors
9
Inge M van Oort
Radboud University Medical Center
Career Start Year
1995
Number of shared co-authors
10
David Clouston
Career Start Year
1995
Number of shared co-authors
16
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year
1993
Number of shared co-authors
14
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Career Start Year
1993
Number of shared co-authors
7
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year
1991
Number of shared co-authors
9
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year
1987
Number of shared co-authors
2
Freddie C Hamdy
University of Oxford
Career Start Year
1987
Number of shared co-authors
11
Dominique Trudel
Institut du cancer de Montreal
Career Start Year
1985
Number of shared co-authors
25
Eric A Klein
Cleveland Clinic
Career Start Year
1984
Number of shared co-authors
16
Lawrence D True
University of Washington School of Medicine
Career Start Year
1980
Number of shared co-authors
12
row(s) 1 - 30 of 30
Collaborators
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Co-authored papers
26
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers
18
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers
13
Esther I Verhoef
Erasmus University Medical Center
Co-authored papers
8
Sebastiaan Remmers
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers
5
Ewout W Steyerberg
Leiden University Medical Center
Co-authored papers
4
Agnes Marije Hoogland
Erasmus Medical Center
Co-authored papers
3
Ren?? B??ttcher
Universitat Pompeu Fabra
Co-authored papers
2
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Co-authored papers
2
Emilie Lalonde
University of Pennsylvania
Co-authored papers
2
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Julie Livingstone
University of California los angeles
Co-authored papers
2
Paul C Boutros
University of California los angeles
Co-authored papers
2
Guido Jenster
Erasmus University Medical Center
Co-authored papers
2
Robert G Bristow
University of Toronto
Co-authored papers
2
Ronald de Wit
Erasmus MC Cancer Institute
Co-authored papers
2
Peter A Humphrey
Yale University School of Medicine
Co-authored papers
2
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers
1
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers
1
Fouad Yousif
Ontario Institute for Cancer Research
Co-authored papers
1
Adeboye O Osunkoya
Emory University School of Medicine
Co-authored papers
1
Alan Dal Pra
University of Miami Miller School of Medicine
Co-authored papers
1
John R Srigley
University of Toronto
Co-authored papers
1
Winnie Lo
The Hospital for Sick Children
Co-authored papers
1
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers
1
Val??rie Picard
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers
1
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers
1
Lars Egevad
Karolinska Institute
Co-authored papers
1
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers
1
1 - 30